Literature DB >> 24084614

Revised 4-dose vaccine schedule as part of postexposure prophylaxis to prevent human rabies.

Manoj K Mittal1.   

Abstract

There is overwhelming evidence that the 4-dose vaccine schedule as part of postexposure prophylaxis to prevent human rabies for previously unvaccinated persons, as recommended by the Advisory Committee on Immunization Practices, United States in 2009, is safe and effective. When used appropriately with timely wound care and administration of human rabies immune globulin, the administration of 4 doses of vaccine on days 0, 3, 7, and 14 is likely to induce an adequate,long-lasting antibody response that is able to neutralize rabies virus and prevent disease in exposed patients. There has been no change in the recommended regimen for pre-exposure prophylaxis and for postexposure prophylaxis of previously vaccinated persons or for immunosuppressed patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24084614     DOI: 10.1097/PEC.0b013e3182a63125

Source DB:  PubMed          Journal:  Pediatr Emerg Care        ISSN: 0749-5161            Impact factor:   1.454


  1 in total

1.  Isatis indigotica root polysaccharides as adjuvants for an inactivated rabies virus vaccine.

Authors:  Weijiao Zhang; Xuexing Zheng; Nan Cheng; Weiwei Gai; Xianghong Xue; Yuxia Wang; Yuwei Gao; Junjie Shan; Songtao Yang; Xianzhu Xia
Journal:  Int J Biol Macromol       Date:  2016-02-10       Impact factor: 6.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.